Azacitidine and lenalidomide as an alternative treatment for refractory acute myeloid leukemia: a case report. [electronic resource]
Producer: 20160108Description: 271-4 p. digitalISSN:- 1806-9460
- Angiogenesis Inhibitors -- administration & dosage
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Azacitidine -- administration & dosage
- Female
- Humans
- Lenalidomide
- Leukemia, Myeloid, Acute -- drug therapy
- Middle Aged
- Reproducibility of Results
- Thalidomide -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.